Sontag Advisory »

Regeneron Pharmaceuticals shares owned by Sontag Advisory

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Sontag Advisory from 13F filings

Historical chart of Sontag Advisory investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Sontag Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Sontag Advisory

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.5M 8.1k 1051.24
2024-06-30 $493k 469 1051.03
2024-03-31 $466k 484 962.49
2023-12-31 $473k 538 878.29
2023-09-30 $377k 458 822.96
2023-06-30 $318k 442 718.54
2023-03-31 $204k 248 821.67
2022-12-31 $207k 287 721.49
2021-03-31 $340k 718 473.54
2020-12-31 $1.7M 3.5k 483.21
2020-09-30 $1.6M 2.9k 559.82
2020-06-30 $1.5M 2.4k 623.65
2020-03-31 $1.0M 2.1k 488.10
2019-12-31 $345k 918 375.82
2019-09-30 $262k 945 277.25
2018-12-31 $68k 182 373.63